Drugs Containing Excipient (Inactive Ingredient) OCTISALATE

Branded drugs containing OCTISALATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Padagis US LLC	EVAMIST	estradiol	0574-2067	OCTISALATE
Physicians Total Care Inc	EVAMIST	estradiol	54868-6157	OCTISALATE
Physicians Total Care Inc	AXIRON	testosterone	54868-6406	OCTISALATE
Ther-Rx Corporation	EVAMIST	estradiol	64011-215	OCTISALATE

Generic drugs containing OCTISALATE excipient

Company	Ingredient	NDC	Excipient
Padagis US LLC	estradiol	0574-2067	OCTISALATE
Actavis Pharma Inc	testosterone	0591-2114	OCTISALATE
TWi Pharmaceuticals Inc	testosterone	24979-130	OCTISALATE
Padagis Israel Pharmaceuticals Ltd	testosterone	45802-610	OCTISALATE
Physicians Total Care Inc	estradiol	54868-6157	OCTISALATE
Physicians Total Care Inc	testosterone	54868-6406	OCTISALATE
Alembic Pharmaceuticals Inc	testosterone	62332-488	OCTISALATE

Market Dynamics and Financial Trajectory for OCTISALATE

Last updated: February 22, 2026

What is OCTISALATE and its primary application?

OCTISALATE is a specialized pharmaceutical excipient used predominantly in skincare formulations. It acts as a UV-filtering agent and oil control agent within topical products. Its primary application is in products designed to reduce facial shine and protect against UV damage, often found in sunscreens and oil-control cosmetics.

How does the market for OCTISALATE develop globally?

The global market for OCTISALATE and similar UV-filtering excipients is driven by increasing demand for broad-spectrum sunscreens, rising awareness about skin health, and increasing prevalence of skin diseases linked to UV exposure.

Market size and growth rates

• The global sunscreen market was valued at approximately USD 11 billion in 2022.
• It is projected to grow at a CAGR of 5.4% from 2023 to 2030, reaching USD 16 billion by 2030 [1].
• OCTISALATE accounts for an estimated 10% of globally used UV filtering agents in formulations.

Distribution by region (2022 estimates)

Region	Market Share (%)	Growth Rate (2023-2030)
North America	35	5%
Europe	27	4.8%
Asia-Pacific	25	6.2%
Latin America	8	4.5%
Rest of World	5	3.9%

The Asia-Pacific region dominates growth due to increasing consumption of skincare products, urbanization, and expanding middle-class markets.

What are the factors influencing demand?

• Consumer preference for oil-free, lightweight formulations.
• Regulatory approvals favoring less toxic, non-nano UV filters.
• Innovation in delivery systems enhancing UV filter stability.
• Rising environmental concerns prompting shifts toward more sustainable excipients.

Consumer and industry trends

• Preference for non-nano UV filters with low skin penetration.
• Growing demand for sunscreen products in emerging markets.
• Formulation innovation leading to targeted skin benefits (e.g., oil control).

Who are the key players?

• Croda International Plc [2]
• BASF SE [3]
• Evonik Industries AG [4]
• Merck KGaA [5]
• Symrise AG [6]

These companies produce OCTISALATE as part of their broad portfolio of cosmetics and pharmaceutical excipients. Their market strategies include innovation, regional expansion, and licensing agreements.

How is the financial landscape shaping?

The excipient market's financial trajectory is tied to the broader cosmetics and pharmaceutical formulations market.

Revenue projections

• The global UV filter market, including OCTISALATE and similar agents, was valued at USD 2.2 billion in 2022.
• Projected to grow at approximately 6% CAGR through 2030, reaching USD 3.9 billion.

R&D and licensing investment

• Major companies invest between 3-5% of revenue into R&D to develop new excipients and improve existing ones.
• Licensing agreements and joint ventures are common, aimed at expanding regional access.

Pricing trends

• Average wholesale prices for OCTISALATE are rising modestly, driven by raw material costs and demand.
• Price elasticity remains low due to the specialized nature of the compound and limited substitutes.

What are the challenges and opportunities?

Challenges

• Strict regulatory requirements for UV filters.
• Potential environmental toxicity concerns (e.g., coral reef impact).
• Competition from alternative UV filter agents with higher efficacy or lower costs.

Opportunities

• Development of eco-friendly, biodegradable versions.
• Expanding applications into novel delivery systems.
• Increasing adoption in emerging markets.

Key Takeaways

• OCTISALATE's market growth parallels the expanding global sunscreen market, with regional variations favoring Asia-Pacific.
• Demand is influenced by consumer preferences for sustainable, low-toxicity ingredients and innovative formulations.
• Major excipient producers are investing heavily in R&D and regional expansion.
• Prices are trending upward due to raw material costs, with limited substitutes maintaining price stability.
• Environmental considerations could sway future regulatory and consumer acceptance.

FAQs

Q1: What factors drive the growth of OCTISALATE in the skincare industry?
Demand for oil-free, lightweight sunscreens and regulations favoring less toxic UV filters.

Q2: How does regional variation impact OCTISALATE's market?
Growth is strongest in Asia-Pacific, driven by expanding middle-class and skincare markets.

Q3: Are there environmental concerns associated with OCTISALATE?
Potential toxicity to marine ecosystems raises concern, prompting development of eco-friendly substitutes.

Q4: Which companies dominate the OCTISALATE market?
Croda, BASF, Evonik, Merck, and Symrise.

Q5: What is the outlook for OCTISALATE prices?
Prices are expected to increase modestly through increased raw material costs and demand growth.

---

References

[1] Grand View Research. (2023). Sunscreen Market Size & Trends.

[2] Croda International Plc. (2023). Annual Report.

[3] BASF SE. (2023). Cosmetic Ingredients Portfolio.

[4] Evonik Industries AG. (2023). Market Segments & Products.

[5] Merck KGaA. (2023). Beauty and Care Ingredients.

[6] Symrise AG. (2023). Cosmetic Active Ingredients.